Annals of Neurology · 2020 · 98 citations · 32 references
MedicineEndocrinologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseCognitive AgingCognitive ImpairmentDementia BiomarkersDiabetes MellitusNeurodegenerative DiseasesAlzheimer Disease DementiaAlzheimer Disease ProgressionDiabetes-related Cognitive DeclineInsulin Receptor SignalingInsulin Receptor Substrate SignalingInsulin SignalingInsulin Signaling In The BrainMolecular Neuropathology
Objective To examine associations of molecular markers of brain insulin signaling with Alzheimer disease (AD) and cognition among older persons with or without diabetes. Methods This clinical–pathologic study was derived from a community‐based cohort study, the Religious Orders Study. We studied 150 individuals (mean age at death =87 years, 48% women): 75 with and 75 without diabetes (matched by sex on age at death and education). Using enzyme‐linked immunosorbent assay, immunohistochemistry, and ex vivo stimulation of brain tissue with insulin, we assessed insulin signaling in the postmortem middle frontal gyrus cortex. Postmortem data documented AD neuropathology. Clinical evaluations documented cognitive function proximate to death, based on 17 neuropsychological tests. In adjusted regression analyses, we examined associations of brain insulin signaling with diabetes, AD, and level of cognition. Results Brain insulin receptor substrate‐1 (IRS1) phosphorylation (pS 307 IRS1/total IRS1) and serine/threonine‐protein kinase (AKT) phosphorylation (pT 308 AKT1/total AKT1) were similar in persons with or without diabetes. AKT phosphorylation was associated with the global AD pathology score ( p = 0.001). In contrast, IRS1 phosphorylation was not associated with AD ( p = 0.536). No other associations of insulin signaling were found with the global AD score, including when using the ex vivo brain insulin stimulation method. In secondary analyses, normalized pT 308 AKT1 was positively correlated with both the amyloid burden and tau tangle density, and no other associations of brain insulin signaling with neuropathology were observed. Moreover, normalized pT 308 AKT1 was associated with a lower level of global cognitive function (estimate = −0.212, standard error = 0.097; p = 0.031). Interpretation Brain AKT phosphorylation, a critical node in the signaling of insulin and other growth factors, is associated with AD neuropathology and lower cognitive function. ANN NEUROL 2020;88:513–525
32
Konrad Talbot, Hoau-Yan Wang, Hala Kazi et al. · Journal of Clinical Investigation · 2012 · 1.8K citations · Full text
Medicine, Neurology, Neuroscience +17
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Zoe Arvanitakis, R. J. Wilson, Julia L. Bienias et al. · Archives of Neurology · 2004 · 1.3K citations
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Julie A. Schneider, Zoe Arvanitakis, Sue E. Leurgans et al. · Annals of Neurology · 2009 · 931 citations · Full text
Medicine, Neurology, Neuroscience +17